Allergen immunotherapy: Definition, indication, and reactions

Allergy and Asthma Proceedings

Volumn 33, Issue SUPPL. 1, 2012, Pages

  Georgy, Mary S ^a   Saltoun, Carol A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ALLERGEN IMMUNOTHERAPY; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANAPHYLAXIS; CELLULAR IMMUNITY; DESENSITIZATION; DISEASE CONTROL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ECONOMIC ASPECT; EOSINOPHIL; HUMAN; HUMORAL IMMUNITY; HYMENOPTERA; IMMEDIATE TYPE HYPERSENSITIVITY; MAST CELL; MORBIDITY; NOSE MUCOSA; REGULATORY T LYMPHOCYTE; REVIEW; RISK REDUCTION; SUBCUTANEOUS IMMUNOTHERAPY; TH1 CELL; TH2 CELL; TREATMENT INDICATION; UNITED STATES; IMMUNOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; INJECTIONS, SUBCUTANEOUS;

EID: 84863206592     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3533     Document Type: Review

References (17)

1. Uzzaman A, and Cho SH. Classification of hypersensitivity reactions. Allergy Asthma Proc 33:S96-S99, 2012.
2. Shah R, and Grammer LC. An overview of allergens. Allergy Asthma Proc 33:S2-S5, 2012.
3. Uzzaman A, and Story R. Allergic rhinitis. Allergy Asthma Proc 33:S15-S18, 2012.
4. Koterba AP, and Saltoun CA. Asthma classification. Allergy Asthma Proc 33:S28-S31, 2012.
5. Koterba AP, and Greenberger PA. Stinging insect allergy and venom immunotherapy. Allergy Asthma Proc 33:S12-S14, 2012.
6. Carr TF, and Saltoun CA. Skin testing in allergy. Allergy Asthma Proc 33:S6-S8, 2012.
7. Makhija M, and O'Gorman MRG. Common in vitro tests for allergy and immunology. Allergy Asthma Proc 33:S108-S111, 2012.
8. Grammer LC, and Harris KE. Principles of immunologic management of allergic diseases due to extrinsic antigens. In Patterson's Allergic Diseases, 7th ed. Grammer LC, and Greenberger PA (Eds). Philadelphia, PA: Lippincott, Williams &Wilkins, 187-196, 2009.
9. Nelson HS. Immunotherapy for inhalant allergens. In Middleton's Allergy Principles & Practice, 7th ed. Adkinson NF Jr, Bochner BS, Busse WW, et al. (Eds). Philadelphia, PA: Mosby, 1657-1677, 2009.
10. Joint Task Force on Practice Parameters. American Academy of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Allergen immunotherapy: A practice parameter second update. J Allergy Clin Immunol 120(suppl): S25-S85, 2007.
11. Robison RG, and Pongracic JA. Food allergy. Allergy Asthma Proc 33:S77-S79, 2012.
12. Carr TF, and Saltoun CA. Urticaria and angioedema. Allergy Asthma Proc 33:S70-S72, 2012.
13. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: A practice parameter third update. J Allergy Clin Immunol 127(suppl):S1-S55, 2011.
14. Radtke M, and Grammer LC. Subcutaneous administration of allergen vaccines. In Allergens and Allergen Immunotherapy, 4th ed., revised and expanded. Lockey RF, and Ledford DK (Eds). New York, NY: Marcel Dekker, Inc., 321-332, 2008.
15. Greenberger PA, and Ditto AM. Anaphylaxis. Allergy Asthma Proc 33:S80-S83, 2012.
16. Frew A. Allergen Immunotherapy. J Allergy Clin Immunol 125:S306-S313, 2010.
17. Akdis CA, and Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 123:735-746, 2009.